Prime Medicine, Inc. SEC filings PRME
Prime Medicine, Inc. has 298 filings in SEC EDGAR's recent list, going back to Dec 20, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 4, 2026 | — |
| POSASR | Filing | Mar 3, 2026 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| CORRESP | Letter to the SEC | Dec 18, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2024 | — |
| EFFECT | Filing | Nov 13, 2023 | — |
| CORRESP | Letter to the SEC | Nov 9, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2023 | — |
| SEC STAFF LETTER | Filing | Oct 19, 2022 | — |
| EFFECT | Filing | Oct 19, 2022 | — |
| CERT | Filing | Oct 19, 2022 | — |
| 8-A12B | Filing | Oct 17, 2022 | — |
| CORRESP | Letter to the SEC | Oct 17, 2022 | — |
| CORRESP | Letter to the SEC | Oct 17, 2022 | — |
| CORRESP | Letter to the SEC | Oct 17, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Oct 7, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2022 | — |
| DRS/A | Filing | Aug 5, 2022 | — |
| DRS/A | Filing | May 6, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 11, 2022 | — |
| DRSLTR | Filing | Apr 8, 2022 | — |
| DRS/A | Filing | Apr 8, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2022 | — |
| DRSLTR | Filing | Mar 25, 2022 | — |
| DRS/A | Filing | Mar 25, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2022 | — |
| DRSLTR | Filing | Mar 7, 2022 | — |
| DRS/A | Filing | Mar 7, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2022 | — |
| DRSLTR | Filing | Feb 4, 2022 | — |
| DRS/A | Filing | Feb 4, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2022 | — |
| DRS/A | Filing | Jan 12, 2022 | — |
| DRS | Filing | Dec 20, 2021 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PRME (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1894562
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.